BioLine RX Ltd (BLRX) — Free Cash Flow Generation Index

Latest as of December 2023: 1.00x

BioLine RX Ltd (BLRX) has a Free Cash Flow Generation Index of 1.00x as of December 2023. Free cash flow of ILA4.97 Million represents 1% of operating cash flow (ILA4.99 Million). Explore reinvestment intensity of BioLine RX Ltd to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

ILA4.97 Million

ILA

Operating Cash Flow

ILA4.99 Million

ILA

Capital Expenditures

ILA18.00K

ILA

BioLine RX Ltd Free Cash Flow Generation Index (2010–2010)

Historical FCF Generation Index trend for BioLine RX Ltd across 1 annual periods. For the full cash flow conversion analysis, see BLRX operating cash flow.

Annual Free Cash Flow Generation for BioLine RX Ltd (2010–2010)

Year-by-year Free Cash Flow Generation Index for BioLine RX Ltd. Check BLRX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (ILA)	Operating CF	Capital Expenditures	YoY Change
2010	0.94x	ILA10.80 Million	ILA11.46 Million	ILA660.94K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).